The House of Lords has agreed to the appointment of a new ad-hoc Committee on HIV and AIDS in the UK. The Committee will be chaired by Lord Fowler.
Lord Fowler was Secretary of State for Social Services, with responsibility for public health, between 1981-1987, he played a leading role in developing the first national public awareness campaign.
The Committee will look in detail at HIV and AIDS in the UK. They will publish a Call for Evidence in the New Year and invite written evidence from any interested parties. They will then hold public evidence session before producing a report next summer.
The Membership of the Committee agreed by the House of Lords today is:
Lord Fowler (Chairman)
Baroness McIntosh of Hudnall
Lord Gardiner of Kimble
Baroness Masham of Ilton
Baroness Gould of Potternewton
Lord May of Oxford
Baroness Healy of Primrose Hill
Lord Rea
Baroness Hussein-Ece
Baroness Ritchie of Brompton
Lord McColl of Dulwich
Baroness Tonge
Commenting following the creation of the Committee Lord Fowler, said:
"The Committee’s report will appear almost exactly a quarter of a century since the ‘Don’t Die of Ignorance‘ campaign in 1986. This is a good time to review the success of prevention and treatment policies. In the last 25 years various efforts have been made to check the spread of the infection. Nevertheless today the number of people living with HIV is nearing 100,000.
"The committee will examine whether public education has been effective and how it might be improved; and also the importance of early diagnosis. Currently about 27 per cent of those with HIV do not know that they are infected.
"The committee will examine what improvements can be made in testing and consider evidence of discrimination. A call for evidence will be issued in the New Year.”
http://www.parliament.uk/hivselect
Contact Details
Lords Clerk Mark Davies
Telephone 020 7219 4827
Fax 020 7219 4931
Email daviesma@parliament.uk
HIV and AIDS in the United Kingdom - Uncorrected Evidence (18 January 2011)
Dr Valerie Delpech, Consultant Epidemiologist and Head of Surveillance, Health Protection Agency, Professor Noel Gill, Head of the HIV and STI Department, Health Protection Services Division, Health Protection Agency, and Dr Paul Cosford Interim Executive Director of Health Protection Services, Health Protection Agency
As this information is already in the public domain, questions asked, I have today submitted for the committee's consideration. http://benefits.tcell.org.uk/forums/foi-request-london-specialised-commi... and http://benefits.tcell.org.uk/forums-keywords/benefits/social-care-rights...
In after effect of the committees's request as listed http://www.parliament.uk/HIVSELECT which asks for an acknowledgment, this is impossible to meet given that this information is already available via TCell. It is awaited if this submission will be heard.
Treatment and Cost:
1. I raise for the committee information that London is unique through the Specialist Commissioning Group which manages London PCT’s budget on HIV NHS services, it spent in 2009/2010 £237million (I have enclosed the breakdown of spend)
2. The LSCG budgeted was estimated to be £246m for London and a £9m surplus was returned. In a year where hospitals started to refer people living with HIV to their local GP’s for medication, given this surplus and eventually of payment of medication through the PCT’s why then was this option introduced?
3. I shall under a separate cover the cost of treatment and services provided for London by the NHS next week; I am waiting for some additional information from the LSCG with the amount is recharges to over PCT’s for those who don’t live in London. I shall also add the amount spent per person on social care provided via the AIDS Support Grant.
4. The Health Protection Agency suggests that 28,285 people reside within London, live with HIV/AIDS a further 2,891 access services within London that resides out of London. The HPA estimates a further 20-25% are to be infected but unknown.
5. We ran a survey asking the question “Would you support a Pan London approach, like that of the London Specialist Commission Group collecting together the AIDS Support Grant and additional funding from each London authority to manage as one collective fund to provide HIV social care and support? Of the 62 responses 81.7% were in favour (18.3% - No) and (2 didn’t comment. Comments left said:
I. This is better approach than local authority commissioning as they consistently fail to acknowledge that people are more likely to use HIV/Sexual Health services outside of their borough/PCT area due to stigma etc.
As long as learning’s from failings in previous similar Commissioning groups can be avoided from the outset, a Specialist Commission should work well.
II. Comments (2) other
III. Big PAN- arrangements become unwieldy and very bureaucratic.
IV. I can’t answer some questions as I have no background information so don’t know what the Pan London AIDS Support Grant is or the London Specialist Commission Group? http://benefits.tcell.org.uk/forums-keywords/benefits/social-care-rights-responsibilities-entitlements/aids-support-grant-asgand http://www.londonspecialisedcommissioning.nhs.uk/about_us
V. A Pan London approach to social care for HIV positive people is a good idea in theory. However, in my experience there is always too much bitching and back biting between commissioners, PCT's NHS Services and Voluntary Sector agencies, they are all notoriously bad at working collaboratively. As a result services end up fragmented and ad hoc. So yes a Pan London approach would be good but I do not think the organisations who would potentially be involved are professional enough to view the bigger picture of putting the needs of HIV positive people first.
VI. At last it seems that the views of people with HIV are being listened to. The hit and miss provision currently available is unfair and unjust - I live in Haringey where the incompetent council may talk the talk but simply do not have a clue, for example! I don't know who the LSCG are, but I hope to god they have nothing to do with THT - the 'charity' uniquely responsible for the gobbling up of holistically focused charities that actually did something for people with hiv, and their replacement with the current void in services. THT's only fig leaf of respectability has been the notion that they are a 'campaigning' charity, yet the fact that the tragic yet curiously farce-like situation with patchy services has been allowed to develop unchallenged by them - and actually with their tacit approval (e.g. the withdrawal of alternative treatments at London Lighthouse for anyone who happened not to have a home in a particular location - although, funnily enough, my hiv virus didn't show a similar preference as to eligible postcodes!!!) is more than sufficient evidence that no one with any association to THT should have anything to do with the AIDS support grant - or anything else connected with hiv for that matter!
VII. Let specialist centres of excellence treat patients such as 56 Dean Street.
VIII. I'm just an ordinary HIV+ Joe who visits my clinic four times a year and takes my pills every night. I haven't a clue what this survey is about or trying to achieve. What's the London Specialist Group? I've no idea. What does 'a Pan London approach' mean? What is a 'Pan London AIDS support Grant'? When you refer to 'each London authority' are you talking about borough councils or primary care trusts or what? This is a survey devised by people who work in the HIV industry and to which I cannot relate. And one other thing. What are these references to AIDS all about? As far as I'm aware, AIDS is something which affects very few people in London (maybe I'm wrong) and is almost obsolescent. I did have AIDS as defined by having an AIDS-related illness when I was first diagnosed with a low CD4 count, but I don't have AIDS now and I find the term has very negative connotations. Please stick to HIV. I was told this was a survey 'for those living with or affected by HIV' - not AIDS.
IX. From my point of view the service is running quite well now. There are pitfalls but overall it is a good service. I think it would be better concentrating on improving what we have rather than making yet another change.
X. I am resident in South London and feel that the way the South London HIV Partnership is modelled is brilliant in particular the Hub & Spoke Peer support work stream which has brought on board providers that are actually in direct contact with people on the ground particularly those that are clearly not offered any support by the larger charities. This has resulted in a tremendous improvement in skills, self-esteem and confidence amongst service users. I doubt very much that a Pan-London approach would manage to achieve this and there is a risk that service delivery would be affected by admin costs. Perhaps North, East and West London (if they have not already) should adopt the SLHP model for PLWH in those areas. http://benefits.tcell.org.uk/forums/south-london-hiv-partnership-funding-and-target-foi-request
XI. Pan London makes most sense and would reintroduce the notion of moving away from health by post code.
XII. I am flexible about who administers the grant, if it goes ahead as a Pan London thing, but whoever it is, it should not be a collection of transient and ill informed commissioners who never stay in post for more than a year and whose ability to deliver progressive services is hamstrung by their lack of experience, either in commissioning per se, HIV services or the London community. This is what has happened in the commissioning of Pan London HIV prevention work, which has made it very hard for those delivering the work to build on successes and learn from mistakes.
XIII. There has been no accountability for how this money has been spent in the past by local authorities. Street lighting? Mending potholes? Certainly hard to see how it has been spent on providing social care for people with HIV. http://benefits.tcell.org.uk/forums-keywords/benefits/social-care-rights-responsibilities-entitlements/aids-support-grant-asg
XIV. Local authorities have not been held accountable for their spend of the ASG to date. This should change in the first instance before it is agreed to farm it out as a Pan London Fund. Local Authorities should report on their spend, activity and outcomes in the area of HIV Social Care and Support. My concern about it becoming Pan London relates to local equity and the lack of evaluation to date on existing Pan London HIV specific programmes. http://benefits.tcell.org.uk/forums-keywords/benefits/social-care-rights-responsibilities-entitlements/aids-support-grant-asg
XV. I would prefer any approach that preserved the administration of ASG money for HIV/AIDS use only.
XVI. A partnership approach needs to be fostered between the PCT's and User Lead Organisations. Any other way seems to create more bureaucracy.....
XVII. A Pan-London approach would be fairer than allowing individual authorities to make decisions and allow for the targeting of resources where needed.
XVIII. None (2)
XIX. Pan London Consortium has its preferences that are incompatible with people's needs. Each local authority knows the needs of their residents better than the Pan London Consortium. http://benefits.tcell.org.uk/forums/foi-request-london-specialised-commission-hiv-budget-200910-201011-and-201112-known
XX. You need to survey patients in HIV Clinics & GP centres.
6. We analysed the AIDS Support grant for London (I have enclosed a copy of this analysis) From the responses we found that 54% contributed more than the ASG allowance received from HM Government, 12% underspent, 24% just spent the ASG allowance and 10% unanswered. The analysis found just 3% of the ASG budget was used for direct payment, current South London is the only area to consolidate via the South London HIV Partnership.
7. I understand that HM Government has made a commitment to keep HIV commissioning as it stands. http://www.theyworkforyou.com/wrans/?id=2011-01-17c.33177.h&s=hiv
8. HM Government have published the AIDS Support grant allocation for the year 2011/12 and 2012/13 http://benefits.tcell.org.uk/forums/aids-support-grant-allocation-201112 and http://benefits.tcell.org.uk/forums/aids-support-grant-allocation-201213
9. An analysis of the trading accounts for various HIV/AIDS/LGBT organisations found:
|
Income |
Costs |
Profit/Loss |
|
|
NAM publications 2007/2008 |
1163379.00 |
1213688.00 |
50309.00 |
|
The Positive Place - 2007/2008 |
486159.00 |
490583.00 |
4424.00 |
|
AVERT - 2008/2009 |
504174.00 |
515716.00 |
11542.00 |
|
Body and Soul 2008/2009 |
1327062.00 |
933422.00 |
393640.00 |
|
DHIVERSE - 2008/2009 |
450293.00 |
476431.00 |
26138.00 |
|
GLBT switchboard - 2008/2009 |
135583.00 |
211041.00 |
75458.00 |
|
GMFA 2008/2009 |
718753.00 |
681043.00 |
37710.00 |
|
NAT - 2008/2009 |
967506.00 |
937704.00 |
29802.00 |
|
NAZ project 2008/2009 |
890093.00 |
861925.00 |
28168.00 |
|
PACE Health - 2008/2009 |
766835.00 |
863965.00 |
97130.00 |
|
Positive East - 2008/2009 |
1656000.00 |
1616000.00 |
40000.00 |
|
Positive Women - 2008/2009 |
586802.00 |
593719.00 |
6917.00 |
|
Stonewall - 2008/2009 |
3843063.00 |
3131913.00 |
711150.00 |
|
The Food Chain 2008/2009 |
432681.00 |
434932.00 |
2251.00 |
|
THT - 2008/2009 |
18019000.00 |
18026000.00 |
7000.00 |
|
£ 31,947,383.00 |
-£ 30,988,082.00 |
£ 959,301.00 |
Click here to see my personnel response to the House of Lords committee on HIV/AIDS within the United Kingdom, if you wish for TCell to publish your personnel comments after acknolwdgement by the House of Lords, please send them to us and we would be happy to post your personnel submissions.
Within my personnel submission, I have included the remarks in context of those listed under the TCell survey asking if you would like a "Pan London approach and administration of the collected AIDS Support Grant and other funding" http://tcell.org.uk/forums/tcell-user-pan-london-services-survey
I have prepared and submitted for the House of Lords Committee on HIV/AIDS in the United Kingdom and aksed for its consideration of the enclosed additional information, this is to put in context, those living with HIV/AIDS and comparission with other main disabling conditions that are in receipt of state support, click here for my response, which also included analysis of Carers and Direct Payments for people who reside within London.
The House of Lords Committee on HIV and AIDS in the UK will take evidence from a range of experts in vaccine and treatment research and development today (Tuesday 1 March).
- Watch the evidence session live on Parliament TV (from 10.15am)
The Committee will hear from the following witnesses:
From 10.15am:
- Rhon Reynolds, Advocacy Specialist Europe, International AIDS Vaccine Initiative
- Mary Kerr, Vice President and Head of ViiV Healthcare Europe, ViiV Healthcare
- Lisa Bright, General Manager UK and Ireland, Gilead Sciences
From 11.15am
- Professor Sir Andrew McMichael, Director, Weatherall Institute of Molecular Medicine, Oxford University
- Professor Jonathan Weber, Deputy Principal (Research), Faculty of Medicine, Imperial College London
- Dr Sheena McCormack, Clinical Epidemiologist, Medical Research Council Clinical Trials Unit
The Committee is investigating issues relating to the monitoring, testing, treatment, prevention and stigma of HIV and AIDS.
The witnesses will be asked questions in relation to:
- progress made towards an HIV vaccine
- agenda-setting for HIV research in the UK
- the major unanswered questions in understanding HIV
- the anticipated effect on HIV treatment and care from the prospect of price competition in the Health and Social Care Bill.
The Evidence session will take place from 10.15am on Tuesday 1 March in Committee Room 2 of the House of Lords.
Public committee sessions are open to everyone, including the press, and follow proceedings from the public gallery.
Further information
The Committee are investigating a wide range of aspects of the current situation on HIV and AIDS including monitoring, testing, treatment, prevention and stigma.
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
The House of Lords Committee on HIV and AIDS in the UK will take evidence from people living with HIV, and from HIV healthcare practitioners today (Tuesday 8 March).
- Watch the evidence session live on Parliament TV (from 10.15am)
The Committee will examine the problems HIV positive people face and whether enough is done to stop people from contracting HIV.
It will ask HIV healthcare practitioners about the treatment and prevention of HIV. It will explore whether NHS reform will adversely affect HIV treatment; whether the ban on home testing kits for HIV should be lifted; and whether migrants should continue to be charged for HIV treatment alongside other issues.
The Committee will hear from the following witnesses:
From 10.15am
Patient group representatives:
- Positive East
- Body and Soul
- Positively UK.
From 11.15am
Healthcare practitioners:
- Dr Simon Barton, Clinical Director of the Directorate of Genitourinary and HIV Medicine at the Chelsea and Westminster Hospital
- Dr Stuart Gibson, Chair, Faculty for HIV and Sexual Health, British Psychological Society
- Nathanial Ault, Chair, National HIV Nurses Association.
The evidence sessions will take place in Committee Room 2 of the House of Lords.
Public committee sessions are open to everyone, including the press, and follow proceedings from the public gallery.
Further information
The House of Lords HIV and AIDS Committee's remit is to consider HIV and AIDS in the United Kingdom. It will report by 20 July 2011. The Committee is investigating issues relating to the monitoring, testing, treatment, prevention and stigma of HIV and AIDS.
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
Brighton and Sussex University Hospital demonstrate how they deliver HIV services
The Brighton and Sussex University Hospital will host the House of Lords Committee on HIV and AIDS in the UK on 15 March to demonstrate how the hospital and its partners deliver HIV services in Brighton.
The Committee will hear from local trailblazers in the prevention and treatment of HIV and AIDS.
The Committee will visit the Sussex Beacon hospice and St Peter’s Medical Practice as well as the hospital to see how HIV services are delivered in Brighton. They will meet patients, carers and Brighton's Community HIV team to understand the perspectives of patients and their carers and they will explore how Brighton’s medical services work in partnership with community care providers.
The Committee's Chairman, Lord Fowler, said:
"The only way we will be able to defeat HIV and AIDS is if we understand what the people who have it, and those who care for them, go through. So I am very glad to be visiting Brighton’s excellent facilities."
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
Evidence gathered by the Committee is available here.
Uncorrected oral evidence
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (15 February 2011) (
)
Published 07 March 2011
John Nawrockyi, Director of Adults and Older People’s Services, London Borough of Greenwich, and Joint Chair of the ADASS Physical Disabilities, HIV and Sensory Impairment Network, Paul Elfick, Senior Specialist Social Worker, Adults and Family Wellbeing, Buckinghamshire County Council and Andrew Pearmain, HIV Consultant Practitioner, Essex County Council
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (15 February 2011) (
)
Published 07 March 2011
Professor Mike Kelly, Director, Centre for Public Health Excellence, NICE
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (08 February 2011) (
)
Published 07 March 2011
Dr Ian Williams, Chair, British HIV Association; Dr Keith Radcliffe, President, British Association for Sexual Health and HIV (BASHH);Chair of the Joint Specialty Committee in Genitourinary Medicine, Royal College of Physicians (Dr Radcliffe is appearing in both capacities); and Ruth Lowbury, Chief Executive, Medical Foundation for AIDS & Sexual Health (MedFASH)
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (01 February 2011) (
)
Published 08 February 2011
Professor David Harper, Director General for Health Improvement and Protection, and Chief Scientist, Department of Health; and Dr Gabriel Scally, Regional Director for Public Health (South West), Department of Health
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (25 January 2011) (
)
Published 02 February 2011
Sir Nick Partridge, Chief Executive, Terrence Higgins Trust; Mr Francis Kaikumba, Chief Executive Officer, African Health Policy Network; Mr Jabulani Chwaula, Programme Manager, African Health Policy Network; Mr Keith Alcorn, Senior Editor, NAM; and Ms Deborah Jack, Chief Executive, National AIDS Trust
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (18 January 2011) (
)
Published 27 January 2011
Dr Valerie Delpech, Consultant Epidemiologist and Head of Surveillance, Health Protection Agency, Professor Noel Gill, Head of the HIV and STI Department, Health Protection Services Division, Health Protection Agency, and Dr Paul Cosford Interim Executive Director of Health Protection Services, Health Protection Agency
-
-
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
GPs and sexual health commissioners will give evidence to the House of Lords Committee investigating HIV and Aids on Tuesday 29 March. The Committee will also visit two London hospitals on Thursday 31 March.
Witnesses
At 10.15am on Tuesday 29 March, a panel of GPs will be questioned about the role of GPs in HIV testing, and whether GPs should take a more prominent role in the treatment and care of those living with HIV. The GPs giving evidence are:
-
Dr Ewen Stewart, Chair, Sex, Drugs and HIV Group, Royal College of GPs
-
Dr Philippa Matthews, Killick Street Health Centre, London
-
Dr Bill Beeby, Chairman, General Practitioners Committee Clinical and Prescribing Sub-Committee, British Medical Association
Immediately following, at 11.15am, the Committee will hear from sexual health and HIV commissioners about subjects including the cost of HIV treatment and care, and whether possible reforms could lower the cost of treatment. Those giving evidence to the Committee in this session are:
-
Sarah Stephenson, Programme Manager, Sexual Health & HIV
-
Greater Manchester Sexual Health Network
-
Justine Womack, Head, Sexual Health South West
-
Simon Williams, Divisional Director, London Specialised Commissioning Group
-
Claire Foreman, Lead Commissioner, London Specialised Commissioning Group
The evidence sessions are open for the public or media to attend and will take place on Tuesday 29 March in Committee Room 2 of the House of Lords.
On Thursday 31 March, the Committee will meet clinicians, staff and patients at the Chelsea and Westminster Hospital, London, and Homerton University Hospital, London.
The Committee will tour the facilities at both hospitals, and will see how treatment programmes and services work, as well as talking to doctors and nurses about topics such as the problems of an ageing HIV patient population and the future of HIV services.
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (08 March 2011) (
)
Published 18 March 2011
Mr Jim Jewers, HIV and Mental Health Worker, Positive East, Ms Annemarie Byrne, Member and Community Representative, Body and Soul, and Ms Silvia Petretti, Community Development Manager, Positively UK
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (01 March 2011) (
)
Published 18 March 2011
Mr Rhon Reynolds, Advocacy Specialist Europe, International AIDS Vaccine Initiative, Dr Emmanuel Cormier, Clinical Immunology Manager, Internationial AIDS Vaccine Initiative, Ms Mary Kerr, VP and Head of Europe, ViiV Healthcare, and Ms Lisa Bright, General Manager UK and Ireland, Gilead Sciences
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (01 March 2011) (
)
Published 18 March 2011
Professor Sir Andrew McMichael, Director, Weatherall Institute of Molecular Medicine, Oxford University, Professor Jonathan Weber, Deputy Principal, Faculty of Medicine, Imperial College London and Dr Sheena McCormack, Clinical Epidemiologist, Medical Research Council Clinical Trials Unit
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (08 March 2011) (
)
Published 18 March 2011
Dr Simon Barton, Clinical Director of the Directorate of Genitourinary and HIV Medicine at the Chelsea and Westminster Hospital, Dr Stuart Gibson, Chair, Faculty for HIV and Sexual Health, British Psychological Society, Mr Nathaniel Ault, Chair, National HIV Nurses Association, and Ms Sharon Byrne, Chair UK HIV Pharmacy Association
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (15 February 2011) (
)
Published 07 March 2011
John Nawrockyi, Director of Adults and Older People’s Services, London Borough of Greenwich, and Joint Chair of the ADASS Physical Disabilities, HIV and Sensory Impairment Network, Paul Elfick, Senior Specialist Social Worker, Adults and Family Wellbeing, Buckinghamshire County Council and Andrew Pearmain, HIV Consultant Practitioner, Essex County Council
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (15 February 2011) (
)
Published 07 March 2011
Professor Mike Kelly, Director, Centre for Public Health Excellence, NICE
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (08 February 2011) (
)
Published 07 March 2011
Dr Ian Williams, Chair, British HIV Association; Dr Keith Radcliffe, President, British Association for Sexual Health and HIV (BASHH);Chair of the Joint Specialty Committee in Genitourinary Medicine, Royal College of Physicians (Dr Radcliffe is appearing in both capacities); and Ruth Lowbury, Chief Executive, Medical Foundation for AIDS & Sexual Health (MedFASH)
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (01 February 2011) (
)
Published 08 February 2011
Professor David Harper, Director General for Health Improvement and Protection, and Chief Scientist, Department of Health; and Dr Gabriel Scally, Regional Director for Public Health (South West), Department of Health
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (25 January 2011) (
)
Published 02 February 2011
Sir Nick Partridge, Chief Executive, Terrence Higgins Trust; Mr Francis Kaikumba, Chief Executive Officer, African Health Policy Network; Mr Jabulani Chwaula, Programme Manager, African Health Policy Network; Mr Keith Alcorn, Senior Editor, NAM; and Ms Deborah Jack, Chief Executive, National AIDS Trust
-
HIV and AIDS in the United Kingdom - Uncorrected Evidence (18 January 2011) (
)
Published 27 January 2011
Dr Valerie Delpech, Consultant Epidemiologist and Head of Surveillance, Health Protection Agency, Professor Noel Gill, Head of the HIV and STI Department, Health Protection Services Division, Health Protection Agency, and Dr Paul Cosford Interim Executive Director of Health Protection Services, Health Protection Agency
-
-
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
On Thursday 31 March, the Committee investigating HIV and Aids will meet clinicians, staff and patients at the Chelsea and Westminster Hospital, London, and Homerton University Hospital, London.
The Committee will tour the facilities at both hospitals, and will see how treatment programmes and services work, as well as talking to doctors and nurses about topics such as the problems of an ageing HIV patient population and the future of HIV services.
Evidence session
The visit follows an evidence session on Tuesday 29 March when the Committee heard from GPs and sexual health commissioners.
The Committee heard from a panel of GPs about the role of GPs in HIV testing, and whether GPs should take a more prominent role in the treatment and care of those living with HIV. The panel of GPs included:
-
Dr Ewen Stewart, Chair, Sex, Drugs and HIV Group, Royal College of GPs
-
Dr Philippa Matthews, Killick Street Health Centre, London
-
Dr Bill Beeby, Chairman, General Practitioners Committee Clinical and Prescribing Sub-Committee, British Medical Association
The Committee also heard from sexual health and HIV commissioners about subjects including the cost of HIV treatment and care, and whether possible reforms could lower the cost of treatment. Those giving evidence to the Committee were:
-
Sarah Stephenson, Programme Manager, Sexual Health & HIV
-
Greater Manchester Sexual Health Network
-
Justine Womack, Head, Sexual Health South West
-
Simon Williams, Divisional Director, London Specialised Commissioning Group
-
Claire Foreman, Lead Commissioner, London Specialised Commissioning Group
-
refer http://www.parliament.uk/documents/lords-committees/hivaids/ucAHHIV03051... (Uncorrected Evidence)
The House of Lords Committee on HIV and AIDS in the UK will take evidence on Tuesday 24 May about sex education in schools from the Minister for Schools, Nick Gibb MP.
Witness
At 10.15am, Tuesday 24 May, Committee Room 2, Palace of Westminster
- Nick Gibb MP, Minister of State for Schools, Department for Education
The Committee will ask the Minister about issues such as whether sex and relationships education (SRE) should be a mandatory part of the school curriculum, how access to SRE will be ensured in academies and faith schools, and the age at which SRE should first be provided in schools.
His assessment of the standard of SRE in schools, how learning around HIV and AIDS is incorporated into current teaching and the training needs of teachers providing SRE will also be topics that the Committee will seek the Minister’s views on.
The Committee is investigating issues relating to the monitoring, testing, treatment, prevention and stigma of HIV and AIDS.
http://www.parliament.uk/business/committees/committees-a-z/lords-select...
Faculty of Public Health submission to the House of Lords Select Committee on HIV and AIDS in the UK – Call ... Will the proposed public health reforms impact on this system?
http://www.fph.org.uk/uploads/HIV%20Lords%20Select%20Committee%20draft%2...
HIV and AIDS in the UK Select Committee - publications
Evidence gathered by the Committee is available here.
Written evidence
-
HIV and AIDS in the United Kingdom - Written Evidence A to M (
) Published 06 May 2011
Written evidence on the inquiry into HIV and AIDS in the United Kingdom from witnesses A to M
-
HIV and AIDS in the United Kingdom - Written Evidence N to Z (
) Published 06 May 2011
Written evidence on the inquiry into HIV and AIDS in the United Kingdom from witnesses N to Z
Oral with associated written evidence
-
HIV and AIDS in the United Kingdom - Oral with associated written evidence (
)
Oral evidence and associated written evidence on the Inquiry into HIV and AIDS in the United Kingdom
Awareness of HIV and AIDS in Britain has fallen below the public radar . In the late 1980s, following the Don't Die of Ignorance campaign, public awareness of the disease was very high. Today the common question asked is—'Is it still a problem?' Perhaps because the scale of the epidemic in Africa is so vast, the undoubted challenge here is pushed to one side. Yet HIV in Britain has not gone away. In recent years, in fact, the number of new diagnoses has been more than double the annual rate seen in the mid-1990s.
By next year there will be over 100,000 people living with the disease. The number of patients has trebled in the last ten years and there is increasing pressure on the health service in dealing with our epidemic. Just as seriously, it is estimated that over a quarter of those living with HIV do not know of their condition. This not only has serious consequences for the individual because treatment is delayed, but also means that the infection is likely to be spread further.
Twenty-five years on from the 1986 campaign there is still no vaccine and, although antiretroviral drugs have dramatically cut the death toll, there is still no cure. These drugs make it possible to successfully live with HIV, but they are also the main reason why the cost of treatment for this entirely preventable disease is now approaching £1 billion a year.
This report examines what is necessary to tackle the epidemic in this country. We believe above all that a new priority must be given to prevention. The advice of the 1980s—on using a condom, on reducing numbers of sexual partners and on not using contaminated needles—remains good today. We argue for a new national campaign to raise public awareness generally, but stress that this is only one part of a general prevention policy.
Prevention measures have already showed their worth. The 1986 campaign, alongside a concerted effort within the gay community, led to a drop in HIV infections and sexually transmitted infections generally; the introduction of needle exchange programmes has meant that in Britain the rate of transmission amongst injecting drug users has remained consistently low compared to a number of other countries; and routine antenatal testing of pregnant women has meant that very few babies are now born with HIV. If new infections can be prevented, then the results are beneficial both in human terms and in savings for the health service, with a lifetime of treatment estimated to cost between £280,000 and £360,000.
In developing a new prevention policy, better testing is a priority. It is in no one's interest that there should be so many people living with undiagnosed HIV. New efforts need to be made to diagnose those infected as early as possible. Tests for pregnant women are now on an 'opt-out' basis, meaning that they will be carried out automatically unless there is an objection. This has been a significant success, and we believe that a sensible next step would be to introduce similar arrangements for all new patients at GP surgeries and general medical admissions, starting in high-prevalence areas.
Our aim is to break down the barriers that stand in the way of people coming forward for testing. For that reason, we propose that testing should go beyond the traditional settings of genitourinary medicine and antenatal clinics. We need to further encourage testing by general practitioners, and ensure that they take a full part in the efforts to reduce HIV. We also propose the legalisation and regulation of home testing.
It is also vital that the stigma and discrimination—based at best on ignorance, and at worst on prejudice—which still surrounds HIV is eliminated. Our evidence shows that even today there are cases of graffiti being sprayed on the houses of people living with HIV. Such acts of discrimination prevent those with HIV coming forward for testing, with serious consequences both for the individual and for public health generally.
We praise the invaluable help of voluntary organisations in tackling HIV, and urge that this should be recognised by the Government and local authorities when they take on greater responsibility for public health. We believe that the Government's proposals for a national public health service with a ring-fenced budget holds great opportunities—but also contains risks that must be avoided. In particular, with HIV services set to be commissioned at both national and local levels, safeguards must be put in place to ensure that HIV is not lost amidst the many competing demands incumbent upon commissioners. We are also concerned that the crucial role that local Directors of Public Health play should be properly recognised.
Traditionally, sexual health has been the poor relation of the health service. Its position is symbolised by the fact that sexual health clinics are too often placed at the very rear of the hospital. We recognise the enormous spending on treatment and care (which also helps in prevention), but deplore the lack of resources devoted to prevention work more generally. Prevention represents the very best investment that any government can make. It can yield significant savings by avoiding future treatment costs which on present projections will inevitably increase. It is only though an effective and coordinated prevention policy that we will start to arrest the numbers of people living with HIV in the United Kingdom, and give proper priority to tackling this disease.
http://www.publications.parliament.uk/pa/ld201012/ldselect/ldaids/188/18...
1st Report - No vaccine, no cure: HIV and AIDS in the United Kingdom the first report from the House of Lords Select committee on HIV and AIDs in the UK
The House of Lords debated the Lords Select Committee on HIV/AIDS report "No vaccine, no cure: HIV and AIDS in the United Kingdom" on the 1st December 2011, World AIDS Day.





The new House of Lords Ad Hoc Committee on HIV and AIDS in the UK has today published a call for evidence for its inquiry.
The Committee are investigating a wide range of aspects of the current situation on HIV and AIDS including monitoring, testing, treatment, prevention and stigma.
Specific questions the Committee have posed in their Call for Evidence include:
The deadline for the submission of written evidence is 18 February 2011.
The Committee will hear evidence from Dr Valerie Delpech, Professor Noel Gill and Dr Paul Cosford at the Health Protection Agency from 10.30am Tuesday 18 January 2011. The Evidence session will be held in Committee Room 2 of the House of Lords. Evidence sessions are held in public.
The Committee will ask questions on the level of infection in the UK, which groups are most severely affected and how effective monitoring of HIV and AIDS in the UK is.
Commenting on the launch of the Call for Evidence Lord Fowler, Chairman of the Committee, said:
“HIV is a significant threat to public health in the UK. Close to 100,000 people live with HIV across the country and 27 per cent of those with HIV do not know they are infected. We will be looking at how to improve testing to reduce the number of those who are unaware of their infection, and will consider whether more needs to be done to raise awareness of the risks.”
“The time is now right to assess whether there is adequate HIV treatment and prevention and how it may be affected by changes to the way services are commissioned in the NHS.
“We will also consider whether public information on the issue is aimed at the right groups and the impact stigmatisation has on those affected by HIV and AIDS.”
http://www.parliament.uk/HIVSELECT